Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Horn EK"'
Autor:
Goorden M, van der Feltz-Cornelis CM, van Steenbergen-Weijenburg KM, Horn EK, Beekman ATF, Hakkaart-van Roijen L
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 13, Pp 1881-1893 (2017)
Maartje Goorden,1 Christina M van der Feltz-Cornelis,2,3 Kirsten M van Steenbergen-Weijenburg,4 Eva K Horn,5 Aartjan TF Beekman,6,7 Leona Hakkaart-van Roijen1 1Institute of Health Policy and Management (iBMG)/Institute for Medical Technology Assessme
Externí odkaz:
https://doaj.org/article/2758308a1b1b4cca98b1f2a9fcafd4b8
Publikováno v:
Personality and Mental Health, 11(3), 206-208. John Wiley & Sons Ltd.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::1342b0d58a3e77bb095cdaff9c850ce2
https://pure.eur.nl/en/publications/e4628e9e-d3d4-4764-baa2-0a1a2cbd73d6
https://pure.eur.nl/en/publications/e4628e9e-d3d4-4764-baa2-0a1a2cbd73d6
Autor:
Horn����ek, Michael
Das Problem der Korrespondenzsuche (oder des Matchings) stellt einen sehr aktiven Forschungsschwerpunkt in mehreren Teilgebieten des Bereichs Computer Vision dar. Bislang hat man sich in der Literatur haupts��chlich auf die Annahme der Brightness
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7db3e0f5770da758da7e0df001f672a
Autor:
Horn EK; GSK, Philadelphia, Pennsylvania, USA., Herrera-Restrepo O; GSK, Philadelphia, Pennsylvania, USA., Acosta AM; GSK, Philadelphia, Pennsylvania, USA., Simon A; OPEN Health Group, Hingham, Massachusetts, USA., Jackson B; OPEN Health Group, Hingham, Massachusetts, USA., Lucas E; OPEN Health Group, Hingham, Massachusetts, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2024 Jul 25; Vol. 230 (1), pp. e199-e218.
Autor:
Perdrizet J; Global Health Economics and Outcomes Research, Pfizer Inc., 235 East 42nd Street, New York, NY, 10017, USA. Johnna.Perdrizet@pfizer.com., Horn EK; Global Health Economics and Outcomes Research, Pfizer Inc., 235 East 42nd Street, New York, NY, 10017, USA., Hayford K; Vaccines Medical Development and Scientific and Clinical Affairs, Pfizer Inc., New York, NY, USA., Grant L; Vaccines Medical Development and Scientific and Clinical Affairs, Pfizer Inc., New York, NY, USA., Barry R; Vaccines Medical Development and Scientific and Clinical Affairs, Pfizer Inc., New York, NY, USA., Huang L; Global Health Economics and Outcomes Research, Pfizer Inc., 235 East 42nd Street, New York, NY, 10017, USA., McDade C; RTI Health Solutions, Research Triangle Park, NC, USA., Wilson M; RTI Health Solutions, Research Triangle Park, NC, USA.
Publikováno v:
Infectious diseases and therapy [Infect Dis Ther] 2023 May; Vol. 12 (5), pp. 1351-1364. Date of Electronic Publication: 2023 Apr 20.
Autor:
Syeed MS; University of Utah College of Pharmacy, Salt Lake City, UT, USA., Ghule P; University of Utah College of Pharmacy, Salt Lake City, UT, USA., Le LM; University of Utah College of Pharmacy, Salt Lake City, UT, USA., Veettil SK; University of Utah College of Pharmacy, Salt Lake City, UT, USA., Horn EK; Pfizer Inc., New York, NY, USA., Perdrizet J; Pfizer Inc., New York, NY, USA., Wasserman M; Pfizer Inc., New York, NY, USA., Thakkinstian A; The Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand., Chaiyakunapruk N; University of Utah College of Pharmacy, Salt Lake City, UT, USA; IDEAS Center, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, UT, USA. Electronic address: nathorn.chaiyakunapruk@utah.edu.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2023 Apr; Vol. 26 (4), pp. 598-611. Date of Electronic Publication: 2022 Oct 31.
Autor:
Blankers M; Department of Research., Smits ML; De Viersprong, Viersprong Institute for Studies on Personality Disorders., Feenstra DJ; De Viersprong, Viersprong Institute for Studies on Personality Disorders., Horn EK; Parnassia Psychiatric Institute., Kamphuis JH; De Viersprong, Viersprong Institute for Studies on Personality Disorders., Bales DL; De Viersprong, Viersprong Institute for Studies on Personality Disorders., Lucas Z; Lentis., Remeeus MGA; De Viersprong, Viersprong Institute for Studies on Personality Disorders., Dekker JJM; Department of Research., Verheul R; Department of Psychiatry., Busschbach JJV; De Viersprong, Viersprong Institute for Studies on Personality Disorders., Luyten P; De Viersprong, Viersprong Institute for Studies on Personality Disorders.
Publikováno v:
Personality disorders [Personal Disord] 2023 Mar; Vol. 14 (2), pp. 207-215. Date of Electronic Publication: 2022 Jun 30.
Autor:
Perdrizet J; Global Health Economics and Outcomes Research, Pfizer Inc., 235 42nd Street, New York, NY, 10017, USA. johnna.perdrizet@pfizer.com., Horn EK; Global Health Economics and Outcomes Research, Pfizer Inc., 235 42nd Street, New York, NY, 10017, USA., Nua W; Pfizer Inc., Makati City, Philippines., Perez-Peralta J; Pfizer Inc., Makati City, Philippines., Nailes J; Research Institute for the Health Sciences, University of the East Ramon Magsaysay Memorial Medical Center, Quezon City, Philippines., Santos J; Infectious Diseases Section, Philippine Children's Medical Center, Quezon City, Philippines., Ong-Lim A; Infectious and Tropical Disease, Department of Pediatrics, College of Medicine-Philippine General Hospital, University of the Philippines, Manila, Philippines.
Publikováno v:
Infectious diseases and therapy [Infect Dis Ther] 2022 Jun; Vol. 11 (3), pp. 1301-1303. Date of Electronic Publication: 2022 Apr 26.
Autor:
Perdrizet J; Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA., Farkouh RA; Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA., Horn EK; Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA., Hayford K; Vaccines Medical Development and Scientific and Clinical Affairs, Pfizer, Inc., Toronto, Canada., Sings HL; Vaccines Medical Development and Scientific and Clinical Affairs, Pfizer, Inc., Collegeville, PA, USA., Wasserman MD; Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA.
Publikováno v:
Expert review of vaccines [Expert Rev Vaccines] 2022 Apr; Vol. 21 (4), pp. 499-511. Date of Electronic Publication: 2022 Feb 22.
Autor:
Lenarčič T; Department of Biology, Institute of Molecular Biology and Biophysics, ETH Zurich, CH-8093 Zurich, Switzerland., Niemann M; Department of Chemistry, Biochemistry, and Pharmaceutical Sciences, University of Bern, CH-3012 Bern, Switzerland., Ramrath DJF; Department of Biology, Institute of Molecular Biology and Biophysics, ETH Zurich, CH-8093 Zurich, Switzerland., Calderaro S; Department of Chemistry, Biochemistry, and Pharmaceutical Sciences, University of Bern, CH-3012 Bern, Switzerland., Flügel T; Department of Biology, Institute of Molecular Biology and Biophysics, ETH Zurich, CH-8093 Zurich, Switzerland., Saurer M; Department of Biology, Institute of Molecular Biology and Biophysics, ETH Zurich, CH-8093 Zurich, Switzerland., Leibundgut M; Department of Biology, Institute of Molecular Biology and Biophysics, ETH Zurich, CH-8093 Zurich, Switzerland., Boehringer D; Department of Biology, Institute of Molecular Biology and Biophysics, ETH Zurich, CH-8093 Zurich, Switzerland., Prange C; Department of Biology, Institute of Molecular Biology and Biophysics, ETH Zurich, CH-8093 Zurich, Switzerland., Horn EK; Department of Chemistry, Biochemistry, and Pharmaceutical Sciences, University of Bern, CH-3012 Bern, Switzerland., Schneider A; Department of Chemistry, Biochemistry, and Pharmaceutical Sciences, University of Bern, CH-3012 Bern, Switzerland andre.schneider@dcb.unibe.ch ban@mol.biol.ethz.ch., Ban N; Department of Biology, Institute of Molecular Biology and Biophysics, ETH Zurich, CH-8093 Zurich, Switzerland; andre.schneider@dcb.unibe.ch ban@mol.biol.ethz.ch.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Jan 18; Vol. 119 (3).